Menu

Top Stories

Published on Thursday, July 11, 2019

Two years have passed since the liver transplant surgery that saved Jude Ward’s life

Two years have passed since the liver transplant surgery that saved Jude Ward’s life

Almost two years have passed since Nicole and Josef Ward’s son, Jude, had a liver transplant due to Alpha-1 Antitrypsin Deficiency (Alpha-1). You can read that story by clicking here.

Most people diagnosed with Alpha-1 don’t exhibit symptoms until they reach adulthood, when underproduction of the alpha-1 antitrypsin protein leads to complications in the lungs and eventual lung disease, according to the Children’s Organ Transplant Association (COTA). However, Jude was producing an abnormal form of the protein, which started pooling in his liver, damaging it.

By 22 months of age, Jude was experiencing serious liver problems. In December 2016, he was rushed to an emergency room, where doctors said Jude would need a life-saving liver transplant to survive.

The family quickly got Jude onto the waiting list for a liver transplant at a hospital in their native Florida, did seemingly endless research on liver disorders in children, and eventually joined COTA.

The Wards, who now live on the joint base, ended up having better luck seeking a transplant at the Children’s Hospital of Philadelphia.

“On July 6, 2017, at 7 am, we got our first call that the hospital had a possible liver match for Jude,” Nicole Ward recalled. “We spent the entire day at the hospital doing pre-op tests on Jude and making him fast only to find out at 9:30 pm that upon retrieval of the liver it was determined not to be the best match for our Jude. We went back to our temporary transplant home broken more than ever but still clinging to a little hope that Jude’s call would come soon,” she added.

A couple of weeks later, Jude was back in the hospital for complications of his liver disease. By July 19, doctors had found a match for him, and the next day, he had a successful surgery.

“We were very relieved but could not quite let ourselves believe this was the one until he was wheeled into surgery about midnight that same night,” Ward said.

In the months leading up to the surgery, the Wards said Jude’s body was failing him. He could only take in food through a feeding tube, he needed infusions to get rid of excess fluid in his stomach, he was tired all the time but could not sleep comfortably, and he would get bruises and sores that didn’t heal.

Though Jude, now 4, had a successful transplant, it still impacts his life in small ways, as he must make frequent visits to the transplant center for lab work, checkups and adjustments to his immunosuppression medications, his family said.

While the family temporarily lived in Philadelphia at the Gift of Life Family House, COTA was able to raise more than $60,000 for COTA in honor of Jude and his medical expenses.

The family also fears they might go through a similar journey all over again. Their daughter Lucie, born last July, has the same deficiency. She is now in the process of receiving regular lab work to check her liver enzymes and regular ultrasounds.

“We do not know where things are headed with Lucie and a liver transplant, but her doctors are keeping a close eye on her,” Ward said.

“Life after transplant is a balance of enjoying life but also being mindful of keeping Jude healthy. The biggest blessing our family has received is the blessing of perspective,” she finished.

Sources: Burlington County Times, Children’s Organ Transplant Association

Photo courtesy of the Children’s Organ Transplant Association.


Print

New US website on Disabilities and Health

Monday, July 26, 2010
The US Centers for Disease Control (CDC) has a new Disabilities and Health website. Some of the new features of the site include: Easy-to-read information on healthy living, secondary conditions, accessibility, and emergency...
Divider

"Bad Blood" film documents tragedy of tainted US blood supply in 1970s-1990s

Monday, July 26, 2010
New York, NY – The documentary film “Bad Blood: A Cautionary Tale,” will premiere Wednesday in New York City as the launch of a theatrical screening series co-hosted by a coalition of national gay rights and hemophilia advocacy...
Divider

Dr. Donohue suggests more Alpha-1 testing

Friday, July 23, 2010
A question today from the syndicated “Dr. Donahue” column DEAR DR. DONOHUE: My wife of 55 years died last year from the complications of an illness known as alpha-1 antitrypsin deficiency. In her late 40s, she would become unduly...
Divider

Patient advocacy group applauds new regulations to strengthen patients' right to appeal health insurance denials

Friday, July 23, 2010
Washington, DC—The National Health Council (NHC) today released a statement in support of today’s White House announcement of new federal regulations to strengthen patients’ rights to appeal health insurance denials. The Alpha-1...
Divider

Charles Leonard Geiger, MD, dies; father of well-known Alpha

Friday, July 16, 2010
GAINESVILLE, GA—Charles Leonard Geiger, MD, died Wednesday, July 14. A retired pathologist, he had formerly been an officer in the US Air Force Medical Service and professor of clinical pathology at Emory Medical School. He was the father...
Divider

Alpha-1 patient in Canada doing well after getting lung transplant despite infection with H1N1 (swine flu) virus

Wednesday, July 14, 2010
CBC News EDMONTON, Alberta—A 50-year-old Canadian with Alpha-1 Antitrypsin Deficiency underwent a successful double lung transplant last year in Edmonton even though he was infected with the H1N1 virus at the time of the surgery, doctors...
Divider

Iowa Alpha-1 education day August 28 features talks on importance of exercise, getting to positive, advocacy opportunities and More

Tuesday, July 6, 2010
DES MOINES, IA – Josh Stolpe, a Cardiopulmonary Specialist at Mercy Medical Center, will explain “The Importance of Exercise” at the Alpha-1 Education Day on August 28. Jeff Wilson, MD, Professor of Medicine at the University of...
Divider

FDA approves Kamada's IV drug Glassia as 4th US augmentation therapy for Alpha-1

Friday, July 2, 2010
Israeli biopharmaceutical company Kamada Inc. has been granted approval by the US Food and Drug Administration for Glassia, its intravenous augmentation therapy to treat emphysema due to Alpha-1 Antitrypsin Deficiency. Alpha-1 Antitrypsin...
Divider

Kathy Haduck receives Helen Chase Walsh Memorial Award

Thursday, June 17, 2010
AlphaNet Coordinator Kathy Haduck of Blandburg, PA, was honored with the Helen Chase Walsh Memorial Award at the recent annual education conference of the Alpha-1 Association in Orlando, FL. The award is presented each year by the Walsh family to...
Divider

Do you have the scoop on Alpha-1?

Thursday, June 17, 2010
Darin and Megan Chittick know exactly why it’s important to support Alpha-1 fundraisers. Their daughter, McKinley Chittick, who is now three years old, was diagnosed with Alpha-1 when she was just a month old. She developed severe jaundice...
Divider

$1 million donation by Cadwgans to help Alpha-1 Foundation "find new therapies and ultimately, a cure"

Wednesday, June 16, 2010
Ruth and Gordon E. Cadwgan, Jr., made a surprise announcement at this past weekend’s national education conference in Orlando: the donation of a million dollars to the Alpha-1 Foundation from themselves and Gordon Cadwgan, Sr. Gordon...
Divider

Foundation scientific director receives "outstanding investigator" award from Hungarian Respiratory Society

Wednesday, June 16, 2010
SOPRON, HUNGARY—Alpha-1 Foundation Scientific Director Adam Wanner, MD, recently received the “Outstanding Investigator Award” from the Hungarian Respiratory Society at its biennial meeting. Wanner gave the keynote speech at the...
Divider
First61626364656667686970

Article Search

Enter keywords in text box and click Search button for results.

Archive